386 related articles for article (PubMed ID: 23656991)
1. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
[TBL] [Abstract][Full Text] [Related]
2. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
Chalmers KA; Love S
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
[TBL] [Abstract][Full Text] [Related]
4. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of spatacsin in α-synucleinopathies.
Kuru S; Yoshida M; Tatsumi S; Mimuro M
Neuropathology; 2014 Apr; 34(2):135-9. PubMed ID: 24112408
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of PSP and MSA: a case report and review of the literature.
Uchikado H; DelleDonne A; Uitti R; Dickson DW
Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
[TBL] [Abstract][Full Text] [Related]
7. Accumulation of phosphorylated alpha-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy.
Nishie M; Mori F; Fujiwara H; Hasegawa M; Yoshimoto M; Iwatsubo T; Takahashi H; Wakabayashi K
Acta Neuropathol; 2004 Apr; 107(4):292-8. PubMed ID: 14722716
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions.
Huang Y; Song YJ; Murphy K; Holton JL; Lashley T; Revesz T; Gai WP; Halliday GM
Acta Neuropathol; 2008 Dec; 116(6):639-46. PubMed ID: 18936941
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of Hsc70 and Hsp70 in glial cytoplasmic inclusions in patients with multiple system atrophy.
Kawamoto Y; Akiguchi I; Shirakashi Y; Honjo Y; Tomimoto H; Takahashi R; Budka H
Brain Res; 2007 Mar; 1136(1):219-27. PubMed ID: 17240362
[TBL] [Abstract][Full Text] [Related]
10. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
11. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
[TBL] [Abstract][Full Text] [Related]
12. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
13. Expanding the spectrum of neuronal pathology in multiple system atrophy.
Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
[TBL] [Abstract][Full Text] [Related]
14. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.
Tu PH; Galvin JE; Baba M; Giasson B; Tomita T; Leight S; Nakajo S; Iwatsubo T; Trojanowski JQ; Lee VM
Ann Neurol; 1998 Sep; 44(3):415-22. PubMed ID: 9749615
[TBL] [Abstract][Full Text] [Related]
15. Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.
Gómez-Tortosa E; Gonzalo I; Newell K; García Yébenes J; Vonsattel P; Hyman BT
Acta Neuropathol; 2002 May; 103(5):495-500. PubMed ID: 11935266
[TBL] [Abstract][Full Text] [Related]
16. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
17. A comparison of changes in proteasomal subunit expression in the substantia nigra in Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Bukhatwa S; Zeng BY; Rose S; Jenner P
Brain Res; 2010 Apr; 1326():174-83. PubMed ID: 20176003
[TBL] [Abstract][Full Text] [Related]
18. alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy.
Sone M; Yoshida M; Hashizume Y; Hishikawa N; Sobue G
Acta Neuropathol; 2005 Jul; 110(1):19-26. PubMed ID: 15895299
[TBL] [Abstract][Full Text] [Related]
19. FBXO7 mutations in Parkinson's disease and multiple system atrophy.
Conedera S; Apaydin H; Li Y; Yoshino H; Ikeda A; Matsushima T; Funayama M; Nishioka K; Hattori N
Neurobiol Aging; 2016 Apr; 40():192.e1-192.e5. PubMed ID: 26882974
[TBL] [Abstract][Full Text] [Related]
20. Neuropathology underlying clinical variability in patients with synucleinopathies.
Halliday GM; Holton JL; Revesz T; Dickson DW
Acta Neuropathol; 2011 Aug; 122(2):187-204. PubMed ID: 21720849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
